Rappel : EACPT virtual meeting 2021, 28th and 29th June
La SFPT vous rappelle que l'EACPT virtual meeting 2021 se tiendra les 28 et 29 juin prochains.
Voici les liens vers le site et le programme:
- Dernière mise à jour le .
La SFPT vous rappelle que l'EACPT virtual meeting 2021 se tiendra les 28 et 29 juin prochains.
Voici les liens vers le site et le programme:
The EACPT has recently been invited to collaborate with the Tufts Center for the Study of Drug Development (Tufts CSDD), in a study aimed to investigate the diversity and disparities among global clinical research sites and identify targeted opportunities to engage and enable this community to more successfully partner with patients and sponsors.
The next EACPT Meeting will be a Virtual Focus Meeting held by 28th - 29th June 2021, and will focus on Progress in Clinical Pharmacology.
Late Breaking Abstract can still be submitted up to May 15th . These abstracts can be accepted only as POSTERS, and will be posted only on the congress website, but they will be published in the European Journal of Clinical Pharmacology like the other abstracts. Abstract submitters must register for the virtual EACPT meeting. Additional information and access can be found at: http://eacpt2021.com/abstract-submission/
Online registration for the Focus meeting will be open by 15th April.
A nos jeunes pharmacologues,
La SFPT vous encourage vivement à répondre à cet appel à candidatures conjoint EPHAR-EACPT ! 2 prix de 1 000 euros chacun pour récompenser votre travail, n'hésitez pas à postuler !
Pour obtenir un justificatif d'appartenance à la SFPT, contactez notre secrétariat : secretariat@sfpt-fr.org
Communication de l'EACPT :
The European Association for Clinical Pharmacology and Therapeutics (EACPT) Young Clinical Pharmacologists Working Group has been working on a research project with the objective to assess the perception of healthcare professionals from all over Europe on medical cannabis and other cannabis-based products. Previous studies have investigated this question; however, it has not yet been assessed in the European countries despite the current changes towards cannabis regulation.
To this end, a survey questionnaire has been prepared that targets all health professionals who are likely to be involved in the prescription, dispensing, and administration of these products, or even in giving advice on them.